Assyro AI

Orange Book product · Brand (NDA)

ACTHAR GEL (AUTOINJECTOR)

CORTICOTROPIN

Brand (NDA)NDA 008372RX MALLINCKRODT IRELAND

At a glance

Feb 29, 2024

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 29, 2024

    2 yr 4 mo ago

  2. Today

  3. Patent 11752199 expires

    Listed method-of-use patent (U-3686) expiration.

    Jul 18, 2041

    in 15 yr 4 mo

  4. Patent 11752199 expires

    Listed method-of-use patent (U-3687) expiration.

    Jul 18, 2041

    in 15 yr 4 mo

  5. Patent 11752199 expires

    Listed method-of-use patent (U-3688) expiration.

    Jul 18, 2041

    in 15 yr 4 mo

Pharmaceutical detail

Active ingredient

CORTICOTROPIN

Strength

40 UNITS/0.5ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 008372

Product number

003

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11752199Jul 18, 2041in 15 yr 4 mo
U-3686
11752199Jul 18, 2041in 15 yr 4 mo
U-3687
11752199Jul 18, 2041in 15 yr 4 mo
U-3688
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.